Home Precision Medicine in Prostate Cancer Precision Medicine in Prostate Cancer Abstracts

Precision Medicine in Prostate Cancer Abstracts

Liver enzyme elevation after (177)Lu-PSMA radioligand therapy for metastasized castration-resistant prostate cancer

Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist

PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease

2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice

2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice

2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice

Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases

Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases

Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases

The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with...

Load more
Subscribe to RSS